Phase II Trial of Molecularly Determined Treatment of Children and Young Adults With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 29 Jul 2017
At a glance
- Drugs Bevacizumab (Primary) ; Erlotinib (Primary) ; Temozolomide (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 25 Jul 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
- 19 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 23 Dec 2013 Planned end date changed from 1 Sep 2013 to 1 Sep 2015 as reported by ClinicalTrials.gov.